                               SEQUENCE LISTING

<110> TELO THERAPEUTICS, INC.
 
<120> SMALL PEPTIDES FOR INHIBITING GABP

<130> TELO002W

<140> PCT/US2019/032323
<141> 2019-05-15

<150> 62/674,587
<151> 2018-05-21

<160> 42    

<170> PatentIn version 3.5

<210> 1
<211> 454
<212> PRT
<213> Homo sapiens

<400> 1
Met Thr Lys Arg Glu Ala Glu Glu Leu Ile Glu Ile Glu Ile Asp Gly 
1               5                   10                  15      


Thr Glu Lys Ala Glu Cys Thr Glu Glu Ser Ile Val Glu Gln Thr Tyr 
            20                  25                  30          


Ala Pro Ala Glu Cys Val Ser Gln Ala Ile Asp Ile Asn Glu Pro Ile 
        35                  40                  45              


Gly Asn Leu Lys Lys Leu Leu Glu Pro Arg Leu Gln Cys Ser Leu Asp 
    50                  55                  60                  


Ala His Glu Ile Cys Leu Gln Asp Ile Gln Leu Asp Pro Glu Arg Ser 
65                  70                  75                  80  


Leu Phe Asp Gln Gly Val Lys Thr Asp Gly Thr Val Gln Leu Ser Val 
                85                  90                  95      


Gln Val Ile Ser Tyr Gln Gly Ile Glu Pro Lys Leu Asn Ile Leu Glu 
            100                 105                 110         


Ile Val Lys Pro Ala Asp Thr Val Glu Val Val Ile Asp Pro Asp Ala 
        115                 120                 125             


His His Ala Glu Ser Glu Ala His Leu Val Glu Glu Ala Gln Val Ile 
    130                 135                 140                 


Thr Leu Asp Gly Thr Lys His Ile Thr Thr Ile Ser Asp Glu Thr Ser 
145                 150                 155                 160 


Glu Gln Val Thr Arg Trp Ala Ala Ala Leu Glu Gly Tyr Arg Lys Glu 
                165                 170                 175     


Gln Glu Arg Leu Gly Ile Pro Tyr Asp Pro Ile Gln Trp Ser Thr Asp 
            180                 185                 190         


Gln Val Leu His Trp Val Val Trp Val Met Lys Glu Phe Ser Met Thr 
        195                 200                 205             


Asp Ile Asp Leu Thr Thr Leu Asn Ile Ser Gly Arg Glu Leu Cys Ser 
    210                 215                 220                 


Leu Asn Gln Glu Asp Phe Phe Gln Arg Val Pro Arg Gly Glu Ile Leu 
225                 230                 235                 240 


Trp Ser His Leu Glu Leu Leu Arg Lys Tyr Val Leu Ala Ser Gln Glu 
                245                 250                 255     


Gln Gln Met Asn Glu Ile Val Thr Ile Asp Gln Pro Val Gln Ile Ile 
            260                 265                 270         


Pro Ala Ser Val Gln Ser Ala Thr Pro Thr Thr Ile Lys Val Ile Asn 
        275                 280                 285             


Ser Ser Ala Lys Ala Ala Lys Val Gln Arg Ala Pro Arg Ile Ser Gly 
    290                 295                 300                 


Glu Asp Arg Ser Ser Pro Gly Asn Arg Thr Gly Asn Asn Gly Gln Ile 
305                 310                 315                 320 


Gln Leu Trp Gln Phe Leu Leu Glu Leu Leu Thr Asp Lys Asp Ala Arg 
                325                 330                 335     


Asp Cys Ile Ser Trp Val Gly Asp Glu Gly Glu Phe Lys Leu Asn Gln 
            340                 345                 350         


Pro Glu Leu Val Ala Gln Lys Trp Gly Gln Arg Lys Asn Lys Pro Thr 
        355                 360                 365             


Met Asn Tyr Glu Lys Leu Ser Arg Ala Leu Arg Tyr Tyr Tyr Asp Gly 
    370                 375                 380                 


Asp Met Ile Cys Lys Val Gln Gly Lys Arg Phe Val Tyr Lys Phe Val 
385                 390                 395                 400 


Cys Asp Leu Lys Thr Leu Ile Gly Tyr Ser Ala Ala Glu Leu Asn Arg 
                405                 410                 415     


Leu Val Thr Glu Cys Glu Gln Lys Lys Leu Ala Lys Met Gln Leu His 
            420                 425                 430         


Gly Ile Ala Gln Pro Val Thr Ala Val Ala Leu Ala Thr Ala Ser Leu 
        435                 440                 445             


Gln Thr Glu Lys Asp Asn 
    450                 


<210> 2
<211> 395
<212> PRT
<213> Homo sapiens

<400> 2
Met Ser Leu Val Asp Leu Gly Lys Lys Leu Leu Glu Ala Ala Arg Ala 
1               5                   10                  15      


Gly Gln Asp Asp Glu Val Arg Ile Leu Met Ala Asn Gly Ala Pro Phe 
            20                  25                  30          


Thr Thr Asp Trp Leu Gly Thr Ser Pro Leu His Leu Ala Ala Gln Tyr 
        35                  40                  45              


Gly His Tyr Ser Thr Thr Glu Val Leu Leu Arg Ala Gly Val Ser Arg 
    50                  55                  60                  


Asp Ala Arg Thr Lys Val Asp Arg Thr Pro Leu His Met Ala Ala Ser 
65                  70                  75                  80  


Glu Gly His Ala Ser Ile Val Glu Val Leu Leu Lys His Gly Ala Asp 
                85                  90                  95      


Val Asn Ala Lys Asp Met Leu Lys Met Thr Ala Leu His Trp Ala Thr 
            100                 105                 110         


Glu His Asn His Gln Glu Val Val Glu Leu Leu Ile Lys Tyr Gly Ala 
        115                 120                 125             


Asp Val His Thr Gln Ser Lys Phe Cys Lys Thr Ala Phe Asp Ile Ser 
    130                 135                 140                 


Ile Asp Asn Gly Asn Glu Asp Leu Ala Glu Ile Leu Gln Ile Ala Met 
145                 150                 155                 160 


Gln Asn Gln Ile Asn Thr Asn Pro Glu Ser Pro Asp Thr Val Thr Ile 
                165                 170                 175     


His Ala Ala Thr Pro Gln Phe Ile Ile Gly Pro Gly Gly Val Val Asn 
            180                 185                 190         


Leu Thr Gly Leu Val Ser Ser Glu Asn Ser Ser Lys Ala Thr Asp Glu 
        195                 200                 205             


Thr Gly Val Ser Ala Val Gln Phe Gly Asn Ser Ser Thr Ser Val Leu 
    210                 215                 220                 


Ala Thr Leu Ala Ala Leu Ala Glu Ala Ser Ala Pro Leu Ser Asn Ser 
225                 230                 235                 240 


Ser Glu Thr Pro Val Val Ala Thr Glu Glu Val Val Thr Ala Glu Ser 
                245                 250                 255     


Val Asp Gly Ala Ile Gln Gln Val Val Ser Ser Gly Gly Gln Gln Val 
            260                 265                 270         


Ile Thr Ile Val Thr Asp Gly Ile Gln Leu Gly Asn Leu His Ser Ile 
        275                 280                 285             


Pro Thr Ser Gly Ile Gly Gln Pro Ile Ile Val Thr Met Pro Asp Gly 
    290                 295                 300                 


Gln Gln Val Leu Thr Val Pro Ala Thr Asp Ile Ala Glu Glu Thr Val 
305                 310                 315                 320 


Ile Ser Glu Glu Pro Pro Ala Lys Arg Gln Cys Ile Glu Ile Ile Glu 
                325                 330                 335     


Asn Arg Val Glu Ser Ala Glu Ile Glu Glu Arg Glu Ala Leu Gln Lys 
            340                 345                 350         


Gln Leu Asp Glu Ala Asn Arg Glu Ala Gln Lys Tyr Arg Gln Gln Leu 
        355                 360                 365             


Leu Lys Lys Glu Gln Glu Ala Glu Ala Tyr Arg Gln Lys Leu Glu Ala 
    370                 375                 380                 


Met Thr Arg Leu Gln Thr Asn Lys Glu Ala Val 
385                 390                 395 


<210> 3
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 3
Leu Lys Glu Ala Asn Asp Glu Ala Gln Lys Tyr Arg Gln Gln Leu Leu 
1               5                   10                  15      


Lys Lys Glu Gln Glu Ala Glu Ala Tyr Arg Gln Lys Leu Glu Ala Met 
            20                  25                  30          


<210> 4
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 4
Leu Asp Glu Ala Asn Arg Glu Ala Lys Lys Tyr Arg Asp Gln Leu Leu 
1               5                   10                  15      


Lys Lys Glu Gln Glu Ala Glu Ala Tyr Arg Gln Lys Leu Glu Ala Met 
            20                  25                  30          


<210> 5
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 5
Leu Asp Glu Ala Asn Arg Glu Ala Gln Lys Tyr Arg Gln Gln Leu Lys 
1               5                   10                  15      


Lys Lys Glu Asp Glu Ala Glu Ala Tyr Arg Gln Lys Leu Glu Ala Met 
            20                  25                  30          


<210> 6
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 6
Leu Asp Glu Ala Asn Arg Glu Ala Gln Lys Tyr Arg Gln Gln Leu Leu 
1               5                   10                  15      


Lys Lys Glu Gln Glu Ala Lys Ala Tyr Arg Asp Lys Leu Glu Ala Met 
            20                  25                  30          


<210> 7
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 7
Leu Asp Glu Ala Asn Arg Glu Ala Gln Lys Tyr Arg Gln Gln Leu Leu 
1               5                   10                  15      


Lys Lys Glu Gln Glu Ala Glu Ala Tyr Arg Lys Lys Leu Glu Asp Met 
            20                  25                  30          


<210> 8
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 8
Leu Lys Glu Ala Asn Asp Glu Ala Gln Lys Tyr Arg Gln Gln Leu Leu 
1               5                   10                  15      


Lys Lys Glu Gln Glu Ala Glu Ala Tyr Arg Lys Lys Leu Glu Asp Met 
            20                  25                  30          


<210> 9
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 9
Leu Asp Glu Ala Asn Arg Glu Ala Lys Lys Tyr Arg Asp Gln Leu Leu 
1               5                   10                  15      


Lys Lys Glu Gln Glu Ala Glu Ala Tyr Arg Lys Lys Leu Glu Asp Met 
            20                  25                  30          


<210> 10
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 10
Leu Asp Glu Ala Asn Arg Glu Ala Gln Lys Tyr Arg Gln Gln Leu Lys 
1               5                   10                  15      


Lys Lys Glu Asp Glu Ala Glu Ala Tyr Arg Lys Lys Leu Glu Asp Met 
            20                  25                  30          


<210> 11
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 11
Ala Lys Lys Tyr Arg Asp Gln Leu Leu Lys Lys Glu Gln Glu Ala Glu 
1               5                   10                  15      


Ala Tyr Arg Gln Lys Leu Glu Ala Met 
            20                  25  


<210> 12
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 12
Ala Gln Lys Tyr Arg Gln Gln Leu Lys Lys Lys Glu Asp Glu Ala Glu 
1               5                   10                  15      


Ala Tyr Arg Gln Lys Leu Glu Ala Met 
            20                  25  


<210> 13
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 13
Ala Gln Lys Tyr Arg Gln Gln Leu Leu Lys Lys Glu Gln Glu Ala Lys 
1               5                   10                  15      


Ala Tyr Arg Asp Lys Leu Glu Ala Met 
            20                  25  


<210> 14
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 14
Ala Gln Lys Tyr Arg Gln Gln Leu Leu Lys Lys Glu Gln Glu Ala Glu 
1               5                   10                  15      


Ala Tyr Arg Lys Lys Leu Glu Asp Met 
            20                  25  


<210> 15
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 15
Ala Lys Lys Tyr Arg Asp Gln Leu Leu Lys Lys Glu Gln Glu Ala Glu 
1               5                   10                  15      


Ala Tyr Arg Lys Lys Leu Glu Asp Met 
            20                  25  


<210> 16
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 16
Ala Gln Lys Tyr Arg Gln Gln Leu Lys Lys Lys Glu Asp Glu Ala Glu 
1               5                   10                  15      


Ala Tyr Arg Lys Lys Leu Glu Asp Met 
            20                  25  


<210> 17
<211> 33
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 17
Ala Lys Lys Tyr Arg Asp Gln Leu Leu Lys Lys Glu Gln Glu Ala Glu 
1               5                   10                  15      


Ala Tyr Arg Lys Lys Leu Glu Asp Met Arg Arg Arg Arg Arg Arg Arg 
            20                  25                  30          


Arg 
    


<210> 18
<211> 43
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 18
Ala Lys Lys Tyr Arg Asp Gln Leu Leu Lys Lys Glu Gln Glu Ala Glu 
1               5                   10                  15      


Ala Tyr Arg Lys Lys Leu Glu Asp Met Leu Leu Ile Ile Leu Arg Arg 
            20                  25                  30          


Arg Ile Arg Lys Gln Ala His Ala His Ser Lys 
        35                  40              


<210> 19
<211> 35
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 19
Ala Lys Lys Tyr Arg Asp Gln Leu Leu Lys Lys Glu Gln Glu Ala Glu 
1               5                   10                  15      


Ala Tyr Arg Lys Lys Leu Glu Asp Met Arg Arg Leu Ser Tyr Ser Arg 
            20                  25                  30          


Arg Arg Phe 
        35  


<210> 20
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 20
Ala Lys Lys Tyr Arg Asp Gln Leu Leu Lys Lys Glu Gln Glu Ala Glu 
1               5                   10                  15      


Ala Tyr Arg Lys Lys Leu Glu Asp Met Tyr Gly Arg Lys Lys Arg Arg 
            20                  25                  30          


Gln Arg Arg Arg 
        35      


<210> 21
<211> 33
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (11)..(11)
<223> Norleucine

<220>
<221> MOD_RES
<222> (25)..(25)
<223> Norleucine

<400> 21
Ala Lys Lys Leu Arg Asp Arg Leu Leu Lys Leu Glu Gln Glu Ala Glu 
1               5                   10                  15      


Ala Leu Arg Lys Lys Leu Glu Asp Leu Arg Arg Arg Arg Arg Arg Arg 
            20                  25                  30          


Arg 
    


<210> 22
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (1)..(37)
<223> D-amino acid

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Norleucine

<220>
<221> MOD_RES
<222> (23)..(23)
<223> Norleucine

<400> 22
Arg Arg Arg Arg Arg Arg Arg Arg Leu Ala Glu Leu Lys Gln Arg Tyr 
1               5                   10                  15      


Ala Glu Ala Glu Gln Glu Leu Lys Leu Leu Gln Gln Arg Tyr Lys Gln 
            20                  25                  30          


Ala Glu Arg Asn Ala 
        35          


<210> 23
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (1)..(37)
<223> D-amino acid

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Norleucine

<220>
<221> MOD_RES
<222> (23)..(23)
<223> Norleucine

<400> 23
Arg Arg Arg Arg Arg Arg Arg Arg Leu Lys Glu Leu Lys Asp Arg Tyr 
1               5                   10                  15      


Ala Glu Ala Glu Gln Glu Leu Lys Leu Leu Gln Gln Arg Tyr Lys Gln 
            20                  25                  30          


Ala Glu Arg Asn Ala 
        35          


<210> 24
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (1)..(37)
<223> D-amino acid

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Norleucine

<220>
<221> MOD_RES
<222> (23)..(23)
<223> Norleucine

<400> 24
Arg Arg Arg Arg Arg Arg Arg Arg Leu Ala Glu Leu Lys Gln Arg Tyr 
1               5                   10                  15      


Ala Glu Ala Glu Gln Glu Leu Lys Leu Leu Gln Lys Arg Tyr Lys Asp 
            20                  25                  30          


Ala Glu Arg Asn Ala 
        35          


<210> 25
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (1)..(37)
<223> D-amino acid

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Norleucine

<220>
<221> MOD_RES
<222> (23)..(23)
<223> Norleucine

<400> 25
Arg Arg Arg Arg Arg Arg Arg Arg Leu Lys Glu Leu Lys Asp Arg Tyr 
1               5                   10                  15      


Ala Glu Ala Glu Gln Glu Leu Lys Leu Leu Gln Lys Arg Tyr Lys Asp 
            20                  25                  30          


Ala Glu Arg Asn Ala 
        35          


<210> 26
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (1)..(37)
<223> D-amino acid

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Norleucine

<220>
<221> MOD_RES
<222> (23)..(23)
<223> Norleucine

<400> 26
Arg Arg Arg Arg Arg Arg Arg Arg Leu Lys Glu Leu Lys Asp Arg Leu 
1               5                   10                  15      


Ala Glu Ala Glu Gln Glu Leu Lys Leu Leu Arg Lys Arg Leu Lys Asp 
            20                  25                  30          


Ala Glu Arg Asn Ala 
        35          


<210> 27
<211> 140
<212> DNA
<213> Homo sapiens

<400> 27
tgaaactcgc gccgcgagga gagggcgggg ccgcggaaag gaaggggagg ggctgggagg       60

gcccggaggg ggctgggccg gggacccggg aggggtcggg acggggcggg gtccgcgcgg      120

aggaggcgga gctggaaggt                                                  140


<210> 28
<211> 140
<212> DNA
<213> Homo sapiens

<400> 28
tgaaactcgc gccgcgagga gagggcgggg ccgcggaaag gaaggggagg ggctgggagg       60

gcccggaagg ggctgggccg gggacccggg aggggtcggg acggggcggg gtccgcgcgg      120

aggaggcgga gctggaaggt                                                  140


<210> 29
<211> 140
<212> DNA
<213> Homo sapiens

<400> 29
tgaaactcgc gccgcgagga gagggcgggg ccgcggaaag gaaggggagg ggctgggagg       60

gcccggaggg ggctgggccg gggacccgga aggggtcggg acggggcggg gtccgcgcgg      120

aggaggcgga gctggaaggt                                                  140


<210> 30
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 30
Arg Arg Arg Arg Arg Arg Arg Arg 
1               5               


<210> 31
<211> 140
<212> DNA
<213> Homo sapiens

<400> 31
tgaaactcgc gccgcgagga gagggcgggg ccgcggaaag gaaggggagg ggctgggagg       60

gcccggaggg ggctgggccg gggacccggg aggggtcggg acggggcggg gtccgcgcgg      120

aggaggcgga gctggaaggt                                                  140


<210> 32
<211> 13
<212> PRT
<213> Human immunodeficiency virus

<400> 32
Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln 
1               5                   10              


<210> 33
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 33
Lys Leu Ala Leu Lys Leu Ala Leu Lys Ala Leu Lys Ala Ala Leu Lys 
1               5                   10                  15      


Leu Ala 
        


<210> 34
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 34
Gly Trp Thr Leu Asn Ser Ala Gly Tyr Leu Leu Gly Lys Ile Asn Leu 
1               5                   10                  15      


Lys Ala Leu Ala Ala Leu Ala Lys Lys Ile Leu 
            20                  25          


<210> 35
<211> 18
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Pegelin  sequence

<400> 35
Arg Gly Gly Arg Leu Ser Tyr Ser Arg Arg Arg Phe Ser Thr Ser Thr 
1               5                   10                  15      


Gly Arg 
        


<210> 36
<211> 16
<212> PRT
<213> Drosophila sp.

<400> 36
Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


<210> 37
<211> 18
<212> PRT
<213> Mus sp.

<400> 37
Leu Leu Ile Ile Leu Arg Arg Arg Ile Arg Lys Gln Ala His Ala His 
1               5                   10                  15      


Ser Lys 
        


<210> 38
<211> 10
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      SynB3 sequence

<400> 38
Arg Arg Leu Ser Tyr Ser Arg Arg Arg Phe 
1               5                   10  


<210> 39
<211> 11
<212> PRT
<213> Human immunodeficiency virus

<400> 39
Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10      


<210> 40
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 40
Ala Gly Tyr Leu Leu Gly Lys Ile Asn Leu Lys Ala Leu Ala Ala Leu 
1               5                   10                  15      


Ala Lys Lys Ile Leu 
            20      


<210> 41
<211> 19
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Angiopep-2 sequence

<400> 41
Thr Phe Phe Tyr Gly Gly Ser Arg Gly Lys Arg Asn Asn Phe Lys Thr 
1               5                   10                  15      


Glu Glu Tyr 
            


<210> 42
<211> 37
<212> PRT
<213> Homo sapiens

<400> 42
Gln Lys Gln Leu Asp Glu Ala Asn Arg Glu Ala Gln Lys Tyr Arg Gln 
1               5                   10                  15      


Gln Leu Leu Lys Lys Glu Gln Glu Ala Glu Ala Tyr Arg Gln Lys Leu 
            20                  25                  30          


Glu Ala Met Thr Arg 
        35          


